Dr. Ruben Raychaudhuri, MD
- Medicare services, 2024
- 12
- Medicare patients, 2024
- 23
- Part D claims, 2024
- 32
- Publications
- 14
- MIPS score, 2024
- 94
- Practice address
- 825 Eastlake Avenue East, Seattle, WA 98109
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
Find Dr. Raychaudhuri's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Ruben Raychaudhuri is a hematologist and oncologist in Seattle, Washington
Dr. Raychaudhuri practices at Fred Hutchinson Cancer Center in Seattle, Washington, part of Fred Hutchinson Cancer Center.
Dr. Raychaudhuri's NPI, 1891282133, was assigned on April 20, 2018. Dr. Raychaudhuri holds Washington license MD61321223.
- NPI
- 1891282133NPI Registry (opens in a new tab)
- Medicare PAC ID
- 5294083861
- NPI enumeration date
- April 20, 2018
- NPI status
- Active
- Accepts Medicare assignment
- Yes
- Offers telehealth
- Yes
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Male
- Estimated age
- 34
- Medical school graduation
- 2018
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)
Dr. Ruben Raychaudhuri practices at Fred Hutchinson Cancer Center in Seattle, Washington
Dr. Raychaudhuri's primary practice is Fred Hutchinson Cancer Center, at 825 Eastlake Avenue East, Seattle, WA 98109.
- Fred Hutchinson Cancer Center825 Eastlake Avenue East, Seattle, WA 98109
Source: Dmand AI Affiliation Data
Dr. Ruben Raychaudhuri is affiliated with 3 sites of care and 1 medical group
Dr. Raychaudhuri's primary practice is Fred Hutchinson Cancer Center in Seattle, Washington, part of Fred Hutchinson Cancer Center. Dr. Raychaudhuri is also affiliated with UW Medical Center - Montlake. The medical group on file is UW Physicians. Dmand AI also links Dr. Raychaudhuri to 1 more hospital, named with a free account.
Sources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data
Dmand AI tracks the EHR system at Dr. Ruben Raychaudhuri's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Raychaudhuri practices, 3 sites in all. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Fred Hutchinson Cancer Center | Available with a free account |
| +2 more affiliated sites | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
Dmand AI maps EHR vendors, IT decision makers and buying committees across Fred Hutchinson Cancer Center and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Ruben Raychaudhuri is one of 348 hematologists and oncologists in Washington
Hematology and oncology is Dr. Raychaudhuri's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Raychaudhuri is licensed in Washington.
Specialties and state licenses
- Hematology and oncology, WashingtonPrimary
Hematologists and oncologists near Dr. Raychaudhuri
Counts of hematologists and oncologists with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Ruben Raychaudhuri billed Medicare for 12 services in 2024
CMS data shows 12 Medicare services from Dr. Raychaudhuri across 1 procedure code in 2024, all of them office visits, for 23 Medicare patients. Medicare paid $1,831 for them. Every service was in an office.
Dr. Raychaudhuri compared with the Washington median for hematologists and oncologists, 2024
- Dr. Raychaudhuri
- Washington median
- Medicare services
- 12vs 58598% below
- Medicare patients
- 23vs 18287% below
- Part D claims
- 12vs 28396% below
Medians across 310 hematologists and oncologists in Washington with Dmand AI profiles that report each measure.
Dr. Raychaudhuri's most billed Medicare procedure codes, 2024
CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.
Need commercial claims for Dr. Raychaudhuri?
Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Raychaudhuri and other hematologists and oncologists in Washington.
Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks
Dr. Ruben Raychaudhuri treated 23 Medicare patients in 2024, average age 75
CMS counts 23 Medicare patients who saw Dr. Raychaudhuri in 2024. 75% of them have cancer, and 70% have high blood pressure. Their average risk score is 1.58, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.
Across all payers, Dmand AI patient panel data puts Dr. Raychaudhuri's median patient age at 74, with 5% women.
Chronic conditions among Dr. Raychaudhuri's Medicare patients, 2024
- Cancer75%
- High blood pressure70%
- High cholesterol65%
Share of Medicare patients with each condition. A patient can have several.
Dr. Raychaudhuri's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 74
Patient panel by sex, all payers
- Women5%
- Men94%
Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data
Dr. Ruben Raychaudhuri wrote 32 Medicare Part D claims in 2024
In 2024, Dr. Raychaudhuri wrote 32 Medicare Part D claims for 13 patients. 91% of them were for generic drugs. CMS names the drug for 12 of them, across 1 drug with 11 or more claims each, at $6,816 in total drug cost. In 2021, CMS named 49 claims across 3 drugs.
Dr. Raychaudhuri's Part D claims by kind of drug, 2024
- Generic29 claims91%
- Brand-name and other3 claims9%
Dr. Raychaudhuri's most prescribed drugs by claims, 2022
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Part D claims for drugs CMS names, 2021 to 2022
- 2021
- 2022
- Claims for drugs CMS names
- 2021: 492022: 1276%
Drugs named by CMS: 1 in 2022, 3 in 2021.
Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data
Dr. Ruben Raychaudhuri scored 94 out of 100 in Medicare's MIPS program for 2024
CMS publishes a Merit-based Incentive Payment System (MIPS) score of 94 out of 100 for Dr. Raychaudhuri for performance year 2024, reported through an alternative payment model (APM). Dr. Raychaudhuri accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Raychaudhuri as offering telehealth.
- Accepts Medicare assignment
- Yes
- Offers telehealth
- Yes
Dr. Raychaudhuri's MIPS scores, performance year 2024
- 94of 100Final score
- 74.6of 100Quality
- 100of 100Promoting Interoperability
- 40of 100Improvement Activities
Each score is out of 100. The final score weighs the categories CMS scored for this clinician.
Sources: Doctors and Clinicians National Downloadable File (CMS); and Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026
For MedTech and pharma teams
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. Ruben Raychaudhuri has 14 publications on record
Dmand AI links 14 papers to Dr. Raychaudhuri, published from 2014 to 2025. 2024 was the busiest year, with 4. The most frequent topics are Neoplasm Metastasis. Dr. Raychaudhuri has published most often in Clin Genitourin Cancer. Dr. Raychaudhuri's most frequent co-authors are Michael Thomas Schweizer, MD, Petros Grivas, MD and Ajjai Shivaram Alva, MD.
Dr. Raychaudhuri's papers by year, 2014 to 2025
Topics Dr. Raychaudhuri writes about most
- Neoplasm Metastasis
Dr. Raychaudhuri's most frequent co-authors
- Michael Thomas Schweizer, MD4 shared papers
- Petros Grivas, MD3 shared papers
- Ajjai Shivaram Alva, MD2 shared papers
Recent publications by Dr. Raychaudhuri
Am Soc Clin Oncol Educ Book
Clin Genitourin Cancer
See who Dr. Raychaudhuri researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Raychaudhuri works with, so you can find a warm path to the right hematologists and oncologists.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. Ruben Raychaudhuri received $47 in industry payments in 2025
CMS Open Payments shows 1 general payment to Dr. Raychaudhuri from 1 drug or device company in 2025. Food and beverage make up the largest share, 100% of the total. Amgen Inc. paid the most, $47.
Companies that paid Dr. Raychaudhuri the most, 2025 to 2025
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Sources for Dr. Ruben Raychaudhuri's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | Dmand AI Affiliation Data |
| Primary practice, affiliations and health system | Dmand AI Affiliation DataDmand AI Org Hierarchy Data |
| Medicare services and procedure codes | Medicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab) |
| State medians for the same specialty | Dmand AI Peer Benchmarks |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab) |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab) |
| MIPS scores, telehealth, assignment and procedure percentiles | Doctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Clinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab) |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Ruben Raychaudhuri
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Ruben Raychaudhuri's NPI number?
Dr. Ruben Raychaudhuri's NPI number is 1891282133. It was assigned on April 20, 2018, and it is active in the NPI Registry.
What kind of doctor is Dr. Ruben Raychaudhuri?
Dr. Ruben Raychaudhuri is a hematologist and oncologist in Seattle, Washington. The primary specialty in the NPI Registry is Hematology & Oncology Physician (taxonomy code 207RH0003X).
Where does Dr. Ruben Raychaudhuri practice?
Dr. Raychaudhuri practices at 825 Eastlake Avenue East, Seattle, WA 98109. Dr. Raychaudhuri's primary practice is Fred Hutchinson Cancer Center in Seattle, Washington, part of Fred Hutchinson Cancer Center. Dmand AI also links Dr. Raychaudhuri to 1 hospital.
What is Dr. Ruben Raychaudhuri's medical license number?
Dr. Raychaudhuri holds Washington license MD61321223.
Which hospitals is Dr. Ruben Raychaudhuri affiliated with?
Dr. Raychaudhuri practices at Fred Hutchinson Cancer Center in Seattle, Washington. Dr. Raychaudhuri is also affiliated with UW Medical Center - Montlake. Dmand AI links Dr. Raychaudhuri to 1 more hospital.
What medical group is Dr. Ruben Raychaudhuri part of?
Dr. Raychaudhuri is linked to UW Physicians.
Does Dr. Ruben Raychaudhuri accept Medicare?
Yes. CMS data shows Dr. Raychaudhuri billed Medicare for 12 services in 2024, and Dr. Raychaudhuri accepts Medicare assignment.
Does Dr. Ruben Raychaudhuri offer telehealth?
Yes. The CMS Doctors and Clinicians file lists Dr. Raychaudhuri as offering telehealth services.
What is Dr. Ruben Raychaudhuri's MIPS score?
Dr. Raychaudhuri's MIPS final score for performance year 2024 is 94 out of 100, reported through an alternative payment model (APM).
How many Medicare patients does Dr. Ruben Raychaudhuri see?
CMS counts 23 Medicare patients who saw Dr. Raychaudhuri in 2024, with an average age of 75.
Show 6 more questionsShow fewer questions
What services does Dr. Ruben Raychaudhuri bill to Medicare?
In 2024, Dr. Raychaudhuri's most billed Medicare services were office visit, new patient (99205).
What drugs does Dr. Ruben Raychaudhuri prescribe most?
In 2022 Medicare Part D data, Dr. Raychaudhuri's most prescribed drugs by claims were Abiraterone Acetate.
Has Dr. Ruben Raychaudhuri received payments from drug or device companies?
CMS Open Payments shows $47 in general payments to Dr. Raychaudhuri from 1 company from 2025 to 2025. The largest total came from Amgen Inc.
How long has Dr. Ruben Raychaudhuri been practicing?
Dr. Raychaudhuri graduated from medical school in 2018, 8 years ago.
Does Dr. Ruben Raychaudhuri do research?
Dmand AI links 14 publications to Dr. Raychaudhuri, published from 2014 to 2025.
Who does Dr. Ruben Raychaudhuri publish with?
Dr. Raychaudhuri's most frequent co-authors are Michael Thomas Schweizer, MD (4 shared papers), Petros Grivas, MD (3 shared papers) and Ajjai Shivaram Alva, MD (2 shared papers).
Selling to hematology and oncology practices?
See hematologists and oncologists in Washington by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card